Le diagnostic et le traitement du mésothéliome peut engendrer des changements sur la peau
- Pustulose exanthématique aigüe généralisée (PEAG) après l’utilisation de Pemextred (antagoniste de l’acide folique)
Acute generalized exanthematous pustulosis after pemetrexed, and recurrence after re-introduction.
Bracke A, Van Marck E, Lambert J.
Clin Exp Dermatol. 2009 Apr;34(3):337-9. Epub 2008 Aug 9.
- Lésions cutanées érysipèloïdes
Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.
Kuku I, Kaya E, Sevinc A, Aydogdu I.
J Eur Acad Dermatol Venereol. 2002 May;16(3):271-2
- Radiodermite
Radiation recall dermatitis with pemetrexed.
Hureaux J, Le Guen Y, Tuchais C, Savary L, Urban T.
Lung Cancer. 2005 Nov;50(2):255-8. Epub 2005 Aug 18.
Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma.
Yajnik S, Rosenzweig KE, Mychalczak B, Krug L, Flores R, Hong L, Rusch VW.
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1319-26.
- Ensemmencement sous-cutanés de foyers tumoraux
Subcutaneous seeding after ultrasound-guided placement of intrapleural catheter. An unusual complication of the intracavitary palliative treatment of pleural mesothelioma.
Sartori S, Nielsen I, Trevisani L, Tassinari D, Abbasciano V.
Support Care Cancer. 1999 Sep;7(5):362-4.
Subcutaneous tumor growth complicating the positioning of Denver shunt and intrapleural port-à-cath in mesothelioma patients.
van Ooijen B, Eggermont AM, Wiggers T.
Eur J Surg Oncol. 1992 Dec;18(6):638-40.
[Metastatic seeding by pleural biopsy].
Blanchette G, Maunier N, Provost G.
Union Med Can. 1973 Feb;102(2):330-4. French.